TY - JOUR
T1 - The association between county-level social determinants of health and cardio-kidney-metabolic disease attributed all-cause mortality in the US
T2 - A cross sectional analysis
AU - Cotton, Antoinette
AU - Salerno, Pedro RVO
AU - Deo, Salil V.
AU - Virani, Salim S.
AU - Nasir, Khurram
AU - Neeland, Ian
AU - Rajagopalan, Sanjay
AU - Sattar, Naveed
AU - Al-Kindi, Sadeer
AU - Elgudin, Yakov E.
N1 - Publisher Copyright:
© 2025
PY - 2025/4
Y1 - 2025/4
N2 - Background: The American Heart Association recently defined cardio-kidney-metabolic (CKM) syndrome as the intersection between metabolic, renal, and cardiovascular disease. Understanding the contemporary estimates of CKM related mortality in the US is essential for developing targeted public interventions. Methods: We analyzed state-level and county-level CKM-associated all-cause mortality data (2010-2019) from the CDC Wide-ranging Online Data for Epidemiologic Research (WONDER). Median and interquartile (IQR) age-adjusted mortality rates (aaMR) per 100,000 were reported and linked with a multi-component metric for social deprivation: the Social Deprivation Index (SDI: range 0 - 100) grouped as: I: 0 – 25, II: 26 – 50, III: 51 – 75, and IV: 75 – 100. We fit pairwise comparisons between SDI groups and evaluated aaMR stratified by sex, race, and location. Results: In 3101 counties, pooled aaMR was 505 (441-579). Oklahoma (643) and Massachusetts (364) had the highest and lowest values. aaMR increased across SDI groups [I: 454(404, 505), IV: 572(IQR: 495.9, 654.7); p < 0.001]. Men had higher rates [602 (526, 687)] than women [427 (368, 491)]. Metropolitan [476 (419, 542)] had lower rates than non-metropolitan counties [521 (454, 596)]. Non-Hispanic Black [637 (545, 731)] had higher rates than non-Hispanic White residents [497 (437, 570]. CKM associated aaMR remained reasonably constant between 2010 and 2019 (Mann Kendall test for trend p-value = 0.99). Conclusions: In the US, CKM mortality disproportionately affects more socially deprived counties. Inability to reduce CKM mortality rates over the study period highlights the need for targeted policy interventions to curb the ongoing high burden.
AB - Background: The American Heart Association recently defined cardio-kidney-metabolic (CKM) syndrome as the intersection between metabolic, renal, and cardiovascular disease. Understanding the contemporary estimates of CKM related mortality in the US is essential for developing targeted public interventions. Methods: We analyzed state-level and county-level CKM-associated all-cause mortality data (2010-2019) from the CDC Wide-ranging Online Data for Epidemiologic Research (WONDER). Median and interquartile (IQR) age-adjusted mortality rates (aaMR) per 100,000 were reported and linked with a multi-component metric for social deprivation: the Social Deprivation Index (SDI: range 0 - 100) grouped as: I: 0 – 25, II: 26 – 50, III: 51 – 75, and IV: 75 – 100. We fit pairwise comparisons between SDI groups and evaluated aaMR stratified by sex, race, and location. Results: In 3101 counties, pooled aaMR was 505 (441-579). Oklahoma (643) and Massachusetts (364) had the highest and lowest values. aaMR increased across SDI groups [I: 454(404, 505), IV: 572(IQR: 495.9, 654.7); p < 0.001]. Men had higher rates [602 (526, 687)] than women [427 (368, 491)]. Metropolitan [476 (419, 542)] had lower rates than non-metropolitan counties [521 (454, 596)]. Non-Hispanic Black [637 (545, 731)] had higher rates than non-Hispanic White residents [497 (437, 570]. CKM associated aaMR remained reasonably constant between 2010 and 2019 (Mann Kendall test for trend p-value = 0.99). Conclusions: In the US, CKM mortality disproportionately affects more socially deprived counties. Inability to reduce CKM mortality rates over the study period highlights the need for targeted policy interventions to curb the ongoing high burden.
KW - Cardiometabolic health
KW - Cardiovascular disease
KW - Diabetes
KW - Kidney disease
KW - Obesity
KW - Renal failure
UR - http://www.scopus.com/inward/record.url?scp=85216640692&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85216640692&partnerID=8YFLogxK
U2 - 10.1016/j.amjms.2025.01.007
DO - 10.1016/j.amjms.2025.01.007
M3 - Article
AN - SCOPUS:85216640692
SN - 0002-9629
VL - 369
SP - 491
EP - 497
JO - American Journal of the Medical Sciences
JF - American Journal of the Medical Sciences
IS - 4
ER -